文献速递肝病炎症性肠病

肥大细胞通过FXR信号调控胆汁淤积中的胆管反应和肠道炎症

Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
PubMed 文献 · Hepatology · 2021-09-09

该研究探讨肥大细胞(MC)表达的FXR在胆汁淤积中对胆管反应(DR)、肝纤维化及肠道炎症的调控作用。在BDL和Mdr2-/-小鼠及PSC患者中,MC-FXR抑制可减少TBA水平、胆管FXR/FGF15表达、DR、纤维化和肠道炎症,提示MC-FXR是潜在治疗靶点。

要点

  • MC-FXR抑制可减轻BDL和Mdr2-/-小鼠的胆管反应、纤维化和肠道炎症。
  • PSC和PSC-IBD患者血清组胺和FGF19水平及SHP表达升高。
  • MC稳定剂色甘酸钠可降低Mdr2-/-小鼠肠道MC浸润和FXR/FGF15表达。

核心结论

  • MC-FXR通过改变胆汁和肠道FXR/FGF15信号调控TBA水平,在肝损伤和胆管反应中起关键作用。

研究设计与样本

  • 研究采用BDL和Mdr2-/-小鼠模型、MC缺陷KitW-sh小鼠及体外实验,并检测PSC和PSC-IBD患者样本。

主要发现

  • 与对照组相比,肝损伤患者MC数量和胆汁FXR表达增加。
  • PSC和PSC-IBD患者血清组胺、FGF19水平及SHP表达较健康对照升高。
  • KitW-sh小鼠注射MC后肝损伤、DR、炎症、胆汁衰老/SASP、纤维化和组胺增加,抑制MC-FXR可减少这些指标。
  • BDL和注射MC的KitW-sh小鼠TBA含量、胆汁FXR/FGF15及肠道炎症增加,而BDL KitW-sh和注射MC-FXR的KitW-sh小鼠上述指标降低。
  • Mdr2-/-小鼠肠道MC浸润和FXR/FGF15表达增加,色甘酸钠稳定MC后降低。

临床怎么用

  • MC-FXR信号通路可能成为胆汁淤积性肝病(尤其PSC合并IBD)的干预靶点。
  • MC稳定剂(如色甘酸钠)在Mdr2-/-小鼠中显示降低肠道MC浸润和FXR/FGF15表达的潜力。

局限性

  • 研究主要基于小鼠模型和体外实验,人类数据为观察性比较,需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Cholestasis is characterized by increased total bile acid (TBA) levels, which are regulated by farnesoid X receptor (FXR)/FGF15. Patients with primary sclerosing cholangitis (PSC) typically present with inflammatory bowel disease (IBD). Mast cells (MCs) (i) express FXR and (ii) infiltrate the liver during cholestasis promoting liver fibrosis. In bile-duct-ligated (BDL) MC-deficient mice (B6.Cg-KitW-sh /HNihrJaeBsmJ [KitW-sh ]), ductular reaction (DR) and liver fibrosis decrease compared with BDL wild type, and MC injection exacerbates liver damage in normal mice. APPROACH AND RESULTS: In this study, we demonstrated that MC-FXR regulates biliary FXR/FGF15, DR, and hepatic fibrosis and alters intestinal FXR/FGF15. We found increased MC number and biliary FXR expression in patients with liver injury compared with control. Histamine and FGF19 serum levels and small heterodimer partner expression increase in patients PSC and PSC-IBD compared with healthy controls. MC injection increased liver damage, DR, inflammation, biliary senescence/senescence-associated secretory phenotype (SASP), fibrosis, and histamine in KitW-sh mice. Inhibition of MC-FXR before injection reduced these parameters. BDL and KitW-sh mice injected with MCs displayed increased TBA content, biliary FXR/FGF15, and intestinal inflammation, which decreased in BDL KitW-sh and KitW-sh mice injected with MC-FXR. MCs increased ileal FXR/FGF15 expression in KitW-sh mice that was reduced following FXR inhibition. BDL and multidrug resistance 2/ATP-binding cassette family 2 member 4 knockout (Mdr2-/- ) mice, models of PSC, displayed increased intestinal MC infiltration and FXR/FGF15 expression. These were reduced following MC stabilization with cromolyn sodium in Mdr2-/- mice. In vitro, MC-FXR inhibition decreased biliary proliferation/SASP/FGF and hepatic stellate cell activation. CONCLUSIONS: Our studies demonstrate that MC-FXR plays a key role in liver damage and DR, including TBA regulation through alteration of intestinal and biliary FXR/FGF15 signaling.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Meadows V, Kennedy L, Ekser B, et al. Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling. Hepatology. 2021. PMID: 34164827. doi:10.1002/hep.32028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。